Overview on Cardiac Cirrhosis and Congestive Hepatopathy - A Review

Mohammed Salah Hussein

Department of Gastroenterology and Endoscopy, Dr Samir Abbas Hospital, Jeddah, Saudi Arabia and Department of Internal Medicine, Faculty of Medicine, Al- Azhar University, Cairo, Egypt.

Sarah Jamal Almujil

KAUH, Saudi Arabia.

Ahmed Saeed S. Banheem

King Abdullah Medical Complex Jeddah, Saudi Arabia.

Nasser Naif Alsuhaymi

Al-Rayan Colleges – Medina, Saudi Arabia.

Mansour Hemaid Alhelali

Medical Rehabilitation Hospital, Saudi Arabia.

Dhiyaa Hassan A. Aldukhi

Graduate, Saudi Arabia.

Khalil Rafed B. Alsaedi

Medical Rehabilitation Hospital, Saudi Arabia.

Naif Mohammed Al-Wagdani

King Abdulaziz Hospital – Rabigh Branch, Saudi Arabia.

Ebtesam Ali S. Almadi

Qassim University, Saudi Arabia.

Khalid Mohammed A. Aladhadh

King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia.

Fahad A. M. R. H. AlAjmi

Farwaniyah Hospital, Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Cardiac cirrhosis (congestive hepatopathy) refers to a group of hepatic abnormalities that develop as a result of right-sided heart failure.  Cirrhosis of the liver can be induced by any right-sided pathology that leads to right-sided heart failure, which leads to increased venous congestion and pressure in the hepatic sinusoids. Because cardiac cirrhosis might be asymptomatic or diagnosed incorrectly due to other types of liver disease, determining its prevalence is difficult. The underlying heart disease, rather than the hepatic congestion and damage, is usually the cause of death in cardiac cirrhosis. The control of the underlying cardiac disease, as well as the optimization of cardiac output, are the mainstays of congestive hepatopathy treatment. Diuresis can help with hepatic congestion, but it must be used with caution to avoid causing hepatic ischemia. Hemodynamic therapy may be able to reverse the early stages of congestive hepatitis. The widespread use of heart transplantation (HT) and considerable breakthroughs in medical and surgical treatments have drastically altered the profile of CH patients. In this overview we will be looking at the disease cause, epidemiology, diagnosis, and treatment.

Keywords: Cardiac cirrhosis, Congestive Hepatopathy, hepatic abnormalities, heart failure


How to Cite

Hussein, M. S., Almujil, S. J., Banheem, A. S. S., Alsuhaymi, N. N., Alhelali, M. H., Aldukhi, D. H. A., Alsaedi, K. R. B., Al-Wagdani, N. M., Almadi, E. A. S., Aladhadh, K. M. A. and AlAjmi, F. A. M. R. H. (2021) “Overview on Cardiac Cirrhosis and Congestive Hepatopathy - A Review”, Journal of Pharmaceutical Research International, 33(47A), pp. 212–220. doi: 10.9734/jpri/2021/v33i47A33006.